Turning Scientific Needs into Innovative Products
Matrix Biotek’s R&D&I activities connect scientific insight, product development and market needs. Our projects may lead to new SHIKARI® assays, KlonArt® products or custom research-use kits for specific research and industry requirements.
Three Product Innovation Routes
Our development work is directed toward practical, reproducible research products—not research activity as an end in itself.
SHIKARI® Innovation
New and expanded research-use assays for biological-drug levels, anti-drug antibodies, neutralising antibodies and related research applications.
Explore SHIKARI® productsKlonArt® Innovation
Antibody-based and other research products developed from selected internal and collaborative innovation projects.
Custom Assays & Kits
Tailored RUO assays and kit formats developed for defined academic, biotechnology, pharmaceutical and laboratory requirements.
Innovation with Product Potential
Selected projects illustrate how Matrix Biotek evaluates scientific opportunities that may progress toward future research-use products.
Human S100A12 Quantitative ELISA
Matrix Biotek and Leitat are working on a joint R&D&I project focused on Human S100A12, a pro-inflammatory calcium-binding protein investigated as a biomarker in inflammatory conditions.
The project is evaluating a quantitative ELISA format for research measurement of Human S100A12 in serum, with the potential to contribute to a future research-use product.
CandidaHunter® — Nanotechnology Blood Culture for Candidemia
An EU Horizon 2020 Phase 1 project exploring a nanotechnology-based blood culture medium for research into detection of invasive Candida in the bloodstream (Grant ID 877651).
The programme investigated the combination of nanotechnology and microbiology as a route toward improved research tools for invasive fungal infections.
Novel Crohn's Disease Serological Markers
This research programme explores novel ASCA epitopes and other serological markers associated with Crohn’s disease.
Its product potential lies in research tools that could complement the SHIKARI® biological-drug monitoring portfolio in IBD research.
Long-COVID Screening Pathway
A research concept combining CoronaHunter® quantitative immunoglobulin measurements with selected vascular and inflammatory biomarkers in studies of persistent post-COVID-19 symptoms.
The programme explores whether combined biomarker panels may support the development of future research products for investigating post-COVID immune responses.
Complementary Expertise,
Product-Oriented Outcomes
Matrix Biotek is open to selected collaborations with academic, research and industry organisations where complementary expertise may accelerate the development of valuable new products.
Joint Innovation Projects
Clearly defined research programmes with credible routes toward useful and differentiated research products.
Industry Development
Custom RUO kit development for biotechnology and pharmaceutical teams working with biologics, biosimilars and immunotherapies.
Scientific Validation
Collaborative studies supporting analytical and research validation of selected assays and product concepts.
Grant-Funded Development
Suitable European and international programmes that can advance well-defined product-development objectives.
Backed by Horizon 2020
Our CandidaHunter® project is recognised by the EU Horizon 2020 programme. Full project details, deliverables and EU funding context are available via the European Commission's CORDIS database.
View on CORDIS ↗Have a Defined Assay or Kit Requirement?
Tell us about the target, intended research application and required format. We can assess whether an existing product, custom development route or selected R&D&I collaboration is appropriate.